Zhu G J, Abbadini M, Donati M B, Mussoni L
Laboratory for Hemostasis and Thrombosis Research, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Am J Physiol. 1989 Feb;256(2 Pt 2):H404-10. doi: 10.1152/ajpheart.1989.256.2.H404.
We have studied the mechanism of release of plasminogen activator (PA) activity induced by epinephrine in the perfused rat hindleg model. Epinephrine perfusion at the dose of 12.5 microM caused a slighter effect on PA activity but an immediate increase in the perfusion pressure. At 25 microM, epinephrine induced a marked increase in PA activity that reached the maximum level at the end of the drug perfusion. The same response was induced by repeated stimulations with epinephrine (25 microM) only if the second stimulus was given 20-25 min apart from the first one. PA release could be blocked by propranolol (300 microM), a nonspecific beta-blocker, and not by phentolamine, a nonspecific alpha-blocker, unless used at very high concentrations (1,250 microM). Perfusion with dibutyryl adenosine 3',5'-cyclic monophosphate (DbcAMP) alone induces an immediate and transient increase in PA activity, but no potentiation could be demonstrated if theophylline was perfused together with epinephrine. The released PA has been characterized on the basis of molecular weight and immunological criteria as t-PA- and u-PA-like molecules in basal conditions. Epinephrine perfusion induced an increase only in the t-PA-like protein. These data indicate that the release of t-PA-like activity observed after epinephrine perfusion is mainly mediated by beta-receptors and is independent from its vasoactive action.
我们已经在灌注大鼠后肢模型中研究了肾上腺素诱导纤溶酶原激活剂(PA)活性释放的机制。12.5微摩尔剂量的肾上腺素灌注对PA活性的影响较小,但会使灌注压力立即升高。25微摩尔时,肾上腺素可诱导PA活性显著增加,并在药物灌注结束时达到最高水平。仅当第二次刺激与第一次刺激间隔20 - 25分钟时,用肾上腺素(25微摩尔)重复刺激才能诱导相同的反应。PA的释放可被非特异性β受体阻滞剂普萘洛尔(300微摩尔)阻断,而非特异性α受体阻滞剂酚妥拉明则不能阻断,除非使用非常高的浓度(1250微摩尔)。单独用二丁酰腺苷3',5'-环磷酸(DbcAMP)灌注可立即短暂增加PA活性,但如果茶碱与肾上腺素一起灌注,则无法证明有增强作用。在基础条件下,根据分子量和免疫学标准,释放的PA已被鉴定为类似组织型纤溶酶原激活剂(t-PA)和尿激酶型纤溶酶原激活剂(u-PA)的分子。肾上腺素灌注仅诱导类似t-PA的蛋白增加。这些数据表明,肾上腺素灌注后观察到的类似t-PA活性的释放主要由β受体介导,且与其血管活性作用无关。